# Lantus biosimilar insulin approved
**URL:** https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240
**Category:** D-News
**Tags:** basal-insulin
**Created:** [January 4, 2022, 5:27pm UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240 "2022-01-04T17:27:57Z")
**Posts on this page:** 6
**Page:** 1
### Author:  [@CatLady](https://forum.fudiabetes.org/u/CatLady)
#### Post date: [January 4, 2022, 5:27pm UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240/1 "2022-01-04T17:27:57Z")
> **[New FDA Approved Insulin Marks Another Win for Insulin Affordability](https://diatribe.org/new-fda-approved-insulin-marks-another-win-insulin-affordability)**
>
> Lilly’s new basal insulin, Rezvoglar, may provide a cheaper alternative to Lantus. This marks the second approval of a biosimilar long-acting insulin.
---
### Author:  [@Boerenkool](https://forum.fudiabetes.org/u/Boerenkool)
#### Post date: [January 4, 2022, 8:39pm UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240/2 "2022-01-04T20:39:17Z")
Lilly already had Basaglar, what’s the difference?
---
### Author:  [@Chris](https://forum.fudiabetes.org/u/Chris)
#### Post date: [January 4, 2022, 8:44pm UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240/3 "2022-01-04T20:44:48Z")
It would seem that either the new biosimilar is cheaper to manufacture, or perhaps Lilly and Novo Nordisk are protecting their profit by creating another market level of insulin to try and prop up their huge profits, by executing a multi-tier product strategy.
---
### Author:  [@Sensorium139](https://forum.fudiabetes.org/u/Sensorium139)
#### Post date: [January 5, 2022, 12:03am UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240/4 "2022-01-05T00:03:28Z")
So we have Basaglar and Semglee, now this?
---
### Author:  [@jbowler](https://forum.fudiabetes.org/u/jbowler)
#### Post date: [January 5, 2022, 3:05am UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240/5 "2022-01-05T03:05:24Z")
Rezvolgar (which shows no results whatsoever on DuckDuckGo as of this moment) is an insulin resplundent with the mythology of the Norse Gods, without the clear suggestions of vomiting called to forth by the previous speeling (RezVoglar), anyway, someone of little merit had already trademarked it.
Marketing experts, well, they told me they were, determined (apparently anabiotically) that my new name was far more appropriate for the modern insulin consuming marketplace. Who am I to believe otherwise?
---
### Author:  [@Boerenkool](https://forum.fudiabetes.org/u/Boerenkool)
#### Post date: [January 5, 2022, 8:30am UTC](https://forum.fudiabetes.org/t/lantus-biosimilar-insulin-approved/12240/6 "2022-01-05T08:30:30Z")
> **[Second Insulin Biosimilar to Get FDA’s Nod—Eli Lilly’s Rezvoglar™ to Enter...](https://biosimilarsrr.com/2021/12/24/second-insulin-biosimilar-to-get-fdas-nod-eli-lillys-rezvoglar-to-enter-the-glargine-market/)**
>
> On December 17, 2021, Eli Lilly received FDA approval of its Rezvoglar (insulin glargine-aglr), a product that is biosimilar to Sanofi’s Lantus®.
Basaglar is not a biosimilar for legal reasons.